Clinical news
Every clinical development we have covered, newest first.
Direct answer
1 dated clinical item. Most recent: Retatrutide reaches 30.3% weight loss in Phase 3 (2026-08-04).
All-in monthly cost at 10 mg
Stories in this category
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.